156 related articles for article (PubMed ID: 35084794)
21. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
Chaudhry MZ; Eschke K; Hoffmann M; Grashoff M; Abassi L; Kim Y; Brunotte L; Ludwig S; Kröger A; Klawonn F; Pöhlmann SH; Cicin-Sain L
J Virol; 2022 Mar; 96(5):e0218621. PubMed ID: 35019723
[TBL] [Abstract][Full Text] [Related]
22. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
[TBL] [Abstract][Full Text] [Related]
23. Molecular Mechanism of Interaction between DNA Aptamer and Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus 2 Variants Revealed by Steered Molecular Dynamics Simulations.
Ding X; Xu C; Zheng B; Yu H; Zheng P
Molecules; 2024 May; 29(10):. PubMed ID: 38792076
[TBL] [Abstract][Full Text] [Related]
24. A high-affinity aptamer with base-appended base-modified DNA bound to isolated authentic SARS-CoV-2 strains wild-type and B.1.617.2 (delta variant).
Minagawa H; Sawa H; Fujita T; Kato S; Inaguma A; Hirose M; Orba Y; Sasaki M; Tabata K; Nomura N; Shingai M; Suzuki Y; Horii K
Biochem Biophys Res Commun; 2022 Jul; 614():207-212. PubMed ID: 35617879
[TBL] [Abstract][Full Text] [Related]
25. In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein.
Lin YC; Chen WY; Hwu ET; Hu WP
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628622
[TBL] [Abstract][Full Text] [Related]
26. Unique Aggregation of Retroviral Particles Pseudotyped with the Delta Variant SARS-CoV-2 Spike Protein.
Petersen JD; Lu J; Fitzgerald W; Zhou F; Blank PS; Matthies D; Zimmerberg J
Viruses; 2022 May; 14(5):. PubMed ID: 35632764
[TBL] [Abstract][Full Text] [Related]
27. Highly-specific aptamer targeting SARS-CoV-2 S1 protein screened on an automatic integrated microfluidic system for COVID-19 diagnosis.
Wu HB; Wang CH; Chung YD; Shan YS; Lin YJ; Tsai HP; Lee GB
Anal Chim Acta; 2023 Sep; 1274():341531. PubMed ID: 37455073
[TBL] [Abstract][Full Text] [Related]
28. Evolution of the SARS-CoV-2 spike protein in the human host.
Wrobel AG; Benton DJ; Roustan C; Borg A; Hussain S; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
Nat Commun; 2022 Mar; 13(1):1178. PubMed ID: 35246509
[TBL] [Abstract][Full Text] [Related]
29. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
[TBL] [Abstract][Full Text] [Related]
30. A Multi-Faceted Binding Assessment of Aptamers Targeting the SARS-CoV-2 Spike Protein.
Civit L; Moradzadeh N; Jonczyk A; Neckermann P; Asbach B; Peterhoff D; Wagner R; Famulok M; Mayer G; Kjems J; Valero J
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731860
[TBL] [Abstract][Full Text] [Related]
31. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.
Zhang L; Li Q; Liang Z; Li T; Liu S; Cui Q; Nie J; Wu Q; Qu X; Huang W; Wang Y
Emerg Microbes Infect; 2022 Dec; 11(1):1-5. PubMed ID: 34890524
[TBL] [Abstract][Full Text] [Related]
32. Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents.
Sánchez-Sendra B; Albert E; Zulaica J; Torres I; Giménez E; Botija P; Beltrán MJ; Rodado C; Geller R; Navarro D
Sci Rep; 2022 Mar; 12(1):3788. PubMed ID: 35260713
[TBL] [Abstract][Full Text] [Related]
33. Temporal-Geographical Dispersion of SARS-CoV-2 Spike Glycoprotein Variant Lineages and Their Functional Prediction Using
Boon SS; Xia C; Wang MH; Yip KL; Luk HY; Li S; Ng RWY; Lai CKC; Chan PKS; Chen Z
mBio; 2021 Oct; 12(5):e0268721. PubMed ID: 34700382
[TBL] [Abstract][Full Text] [Related]
34. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.
Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H
Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
[TBL] [Abstract][Full Text] [Related]
36. A Comparative Study between Spanish and British SARS-CoV-2 Variants.
Jimenez Ruiz JA; Lopez Ramirez C; Lopez-Campos JL
Curr Issues Mol Biol; 2021 Nov; 43(3):2036-2047. PubMed ID: 34889898
[TBL] [Abstract][Full Text] [Related]
37. Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes.
Chatterjee D; Tauzin A; Laumaea A; Gong SY; Bo Y; Guilbault A; Goyette G; Bourassa C; Gendron-Lepage G; Medjahed H; Richard J; Moreira S; Côté M; Finzi A
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062348
[TBL] [Abstract][Full Text] [Related]
38. A Novel Strategy for the Detection of SARS-CoV-2 Variants Based on Multiplex PCR-Mass Spectrometry Minisequencing Technology.
Zhao F; Lu J; Lu B; Qin T; Wang X; Hou X; Meng F; Xu X; Li T; Zhou H; Zhang J; Kan B; Huang Y; Zhang Z; Xiao D
Microbiol Spectr; 2021 Dec; 9(3):e0126721. PubMed ID: 34787499
[TBL] [Abstract][Full Text] [Related]
39.
Reyes CDG; Onigbinde S; Sanni A; Bennett AI; Jiang P; Daramola O; Ahmadi P; Fowowe M; Atashi M; Sandilya V; Hakim MA; Mechref Y
Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759821
[TBL] [Abstract][Full Text] [Related]
40. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
Chakraborty S
Biochem Biophys Res Commun; 2021 Jan; 534():374-380. PubMed ID: 33272568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
